1.05Open1.05Pre Close0 Volume270 Open Interest9.00Strike Price0.00Turnover166.37%IV6.03%PremiumDec 20, 2024Expiry Date0.54Intrinsic Value100Multiplier6DDays to Expiry0.51Extrinsic Value100Contract SizeAmericanOptions Type-0.5690Delta0.2143Gamma8.06Leverage Ratio-0.0598Theta-0.0009Rho-4.58Eff Leverage0.0043Vega
Anavex Life Sciences Stock Discussion
$Sunshine Biopharma (SBFM.US)$
$Rumble (RUM.US)$
Got a few superbouncy balls this evening.
making me dizzy 🤣
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences (Nasdaq: AVXL) announced it will present new long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial for blarcamesine in early Alzheimer's disease at the J.P. Morgan 2025 Healthcare Conference. The presentation will showcase data from up to 144 weeks of continuous treatm...
hmmmmm 🤔 looks very similar throughout the market starting at 3 pm
No comment yet